[Pidotimod causes apoptotic cell death and inhibits the proliferative activity of YAC-1 tumor cells in vitro].
Migliorati
G
G
Dip. di Medicina Clinica, Patologia e Farmacologia, Università di Perugia, Italia.
Nicoletti
I
I
Delfino
D
D
Maggioni
A
A
Coppi
G
G
Riccardi
C
C
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001692:Biological Transport / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D004273:DNA, Neoplasm / Q000032:analysis; D004354:Drug Screening Assays, Antitumor; D016195:G2 Phase / Q000187:drug effects; D016399:Lymphoma, T-Cell / Q000473:pathology; D051379:Mice; D008805:Mice, Inbred A; D008938:Mitosis / Q000187:drug effects; D009363:Neoplasm Proteins / Q000032:analysis; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010750:Phosphoproteins / Q000032:analysis; D010766:Phosphorylation / Q000187:drug effects; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D013601:T-Lymphocytes / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D013844:Thiazoles / Q000494:pharmacology*; D053778:Thiazolidines; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D010750:Phosphoproteins; D013844:Thiazoles; D053778:Thiazolidines; C064893:pidotimod; D002118:Calcium; D011761:Pyrrolidonecarboxylic Acid